Date: 2010-07-09
Name(s): Barton, Cheryl L., Sleigh, Sara
Description: Researchers have a vision that the introduction of imaging biomarkers will revolutionize basic research, drug development and treatment by providing non-invasive approaches that are translatable from the laboratory to the clinic.
Date: 2012-03-28
Name(s): Keighly, Wilma
Description: Advances in target validation, screening technologies, and discovery of new ion channel families combine to enable the investigation and commercialization of this largely unexploited target family with potential in a range of major therapeutic areas.
Date: 2010-11-23
Description: Innovations in medical imaging instrumentation are translations of developments in the fields of particle physics, materials science, nanotechnology, electronics, semiconductor technology, and mechanical engineering.
Date: 2011-11-01
Name(s): Danks, Rachel
Description: There is a growing need for sustainable alternatives to traditional biochemicals. Opportunities exist for companies investing in R&D into renewable chemicals, capitalizing on both increasing market demand and international governmental support.
Date: 2010-11-18
Name(s): Barton, Cheryl L., Sleigh, Sara
Description: As the pharma industry comes under increasing pressure to replenish revenues which are under threat from generic competition, there is an increased focus on technologies and trial designs which aim to maximize success and reduce development time.
Date: 2011-12-21
Name(s): Templeton, David
Description: Early therapeutic intervention to prevent or slow progression of Alzheimer's disease is an urgent medical need. Identification of biomarkers to diagnose AD in the general population and to follow therapeutic effect is a crucial aspect of AD research.
Date: 2012-04-13
Name(s): Haberman, Allan B.
Description: Pharma is running out of druggable targets that have not already been addressed by marketed drugs. Therefore, efforts to tackle protein-protein interactions previously considered undruggable are becoming increasingly important.
Date: 2009-10-24
Name(s): Evers, Paul
Description: A milestone in stem cell technology occurred in 2007, when human cells were induced into a stem cell state using defined genetic factors. These cells, now known as induced pluripotent stem (IPS) cells, offer an alternative to embryonic stem cells.
Date: 2010-10-21
Name(s): Thornton, Peter
Description: Innovative technologies are poised to revolutionize the transdermal drug market. New indications will be opened up to transdermal drug delivery and this will drive growth in the sector.
Date: 2009-10-01
Description: Microarrays and biochips are small devices capable of detecting and measuring large numbers of biomarkers simultaneously. Although microarrays have been in research use for over a decade it is only recently that they have moved towards the clinic.
Date: 2011-06-20
Name(s): Constance, Joseph A.
Description: The global incidence of most forms of cancer continues to increase resulting in a need for more accurate and faster diagnostic techniques. The diagnostics industry is responding to this need and these innovations are driving market growth.
Date: 2012-02-07
Name(s): Humphries, Gavin
Description: Population aging will profoundly affect alcohol consumption over the next decade and beyond. Understanding the complex demands of lucrative, influential consumers aged 50+, is critical to competitiveness in a market typically targeted at the young.
Date: 2009-01-27
Name(s): Eastwood, Gary
Description: With the credit crunch and rising fuel prices emphasizing the need to cut costs and improve efficiency, alongside uncertainty surrounding the impact of human activities on the climate, the drive towards energy efficient computing is gathering pace.
